Dr. Rosenberg admitted he took kickbacks from Insys Therapeutics to prescribe its opioid-based cancer pain drug to patients who did not have cancer.
In the lawsuit, prosecutors claimed Dr. Rosenberg received about $188,000 in speaker fees from Insys Therapeutics from 2012 to 2015. In addition, prosecutors alleged the speaker fees were a factor in his decision to write prescriptions for the highly-addictive opioid-based spray, Subsys, which is only approved by the FDA for use in cancer patients.
The lawsuit also claimed Dr. Rosenberg prescribed Subsys to patients who didn’t have cancer and fraudulently indicated his patients had cancer when they didn’t to ensure reimbursements from payers.
Dr. Rosenberg must also pay $754,736 in restitution, according to the report.
More articles on legal & regulatory issues:
Woman arrested after posing as employee at 2 Tennessee hospitals: 4 things to know
5 latest healthcare industry lawsuits, settlements
Martin Shkreli gets 7 years in prison: 8 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
